Oklahoma dropped its lawsuit against OxyContin-maker Purdue Pharma in exchange for a National Center for Addiction Studies and Treatment in Tulsa.

Renewed interest from the biotech industry sparks hope for drugging the nucleic acid to treat cancer and other conditions.

At least a handful of patients have developed active TB after receiving cancer treatment designed to boost the immune system’s antitumor response.

A long way into the quest to vanquish cancer, our ears strain to hear the words, “Cancer is cured”—a yearning that can cloud our judgment.

A drive for revenue is damaging basic science.

Public health care will take a hit however Britain leaves the European Union, but a no-deal exit will cause the most harm, a new analysis shows.

The group had argued that a patent given to the Broad Institute overlapped with this one.

Immune checkpoint inhibitors are generally most effective against tumors with more genetic mutations, according to a new study, although the relationship isn’t true for all cancers.

Loxo focuses on cancer treatments based on tumor genetics, which will contribute to Lilly’s push in the cancer drug space.

Deep-learning algorithms could help doctors narrow in on the causes of certain medical conditions, say researchers.